ORGANOGENESIS HOLDINGS

Organogenesis Expands Manufacturing Capacity to Support Future Growth

22 11 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Commends Final LCDs

15 11 2024 08:25:44 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results

12 11 2024 15:05:01 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

12 11 2024 15:01:00 提供 Nasdaq GlobeNewswire

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

11 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

16 10 2024 06:30:00 提供 Nasdaq GlobeNewswire

Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

01 10 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

04 9 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results

08 8 2024 15:05:01 提供 Nasdaq GlobeNewswire

Organogenesis Shares ReNu® Program Update

08 8 2024 15:04:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

15 7 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

06 6 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results

09 5 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

02 5 2024 06:00:01 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

16 4 2024 06:30:00 提供 Nasdaq GlobeNewswire

Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case

03 4 2024 06:30:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

29 2 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

12 2 2024 06:30:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

08 2 2024 15:05:00 提供 Nasdaq GlobeNewswire

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

09 11 2023 15:05:00 提供 Nasdaq GlobeNewswire